Winway Health Desk
Nitto Denko lays out $226M to boost oligonucleotide production in a...
With oligonucleotides on the rise to treat rare diseases and cancers, Japanese manufacturer Nitto Denko is laying big plans.
Nitto will plug a whopping 25 billion yen ($225.93...
Pfizer & BioNTech report Covid-19 vaccine shows 100% efficacy in kids...
Pfizer and BioNTech are giving an early look at clinical trial data for their Covid-19 vaccine in children 12 to 15 years old and...
AstraZeneca COVID-19 vaccine gets new Vaxzevria name, but is it enough...
AstraZeneca’s COVID-19 vaccine has an official name, Vaxzevria, now approved in Europe. But is a new name enough to hurdle its rollout communication glitches and...
Merck CEO Frazier joins army of black execs speaking out on...
Merck CEO Kenneth Frazier may be on his way out the drugmaker's door, but his impending retirement isn’t dampening his desire to speak out...
Decentralized clinical trials are opening the drug development pipeline
There is no doubt that the Covid-19 pandemic has had a major impact on life sciences. Not only has it pushed the limits of...
To maximize patient access to care, policies should be modernized to...
While the current Covid-19 pandemic has sped up the adoption of digital health technologies and the virtualization of several aspects of outpatient care—both keys...
GSK ViiV’s Dovato squares off against Evofem’s Phexxi in final #FierceMadness...
The final showdown is set in the FierceMadness DTC ad contest.
Dovato from GlaxoSmithKline’s ViiV Healthcare will go up against Phexxi from Evofem Biosciences for the...
5 Things Not To Do To Your Child
By Dr Renita D’SouzaChildren are like sponge absorbing everything around them, good or bad. They behave as per the experience gained by looking around....
Delivering accurate drug information to point of care, part II
Posted on March 31st, 2021 by Tom Williams in Medical...
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to...
